TROYANOSYVIRUS
Zuruck zu CVEs

CVE-2026-21974

MEDIUM
5.3

Beschreibung

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

CVE Details

CVSS v3.1 Bewertung5.3
SchweregradMEDIUM
CVSS VektorCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
AngriffsvektorNETWORK
KomplexitatLOW
Erforderliche PrivilegienNONE
BenutzerinteraktionNONE
Veroffentlicht1/20/2026
Zuletzt geandert1/29/2026
Quellenvd
Honeypot-Sichtungen0

Betroffene Produkte

oracle:life_sciences_central_designer

Schwachen (CWE)

CWE-200

IOC Korrelationen

Keine Korrelationen erfasst

This product uses data from the NVD API but is not endorsed or certified by the NVD.